24 results
BEE Syndromes - Immune-mediated conditions affecting the brain, eye, and ear

Visual or auditory symptoms in conjunction
Visual or auditory symptoms ... conjunction with symptoms ... diagnosis and treatment ... • Acute disseminated ... #neurology #inflammatory
Acute Spinal Cord Injuries: Pathogenesis and clinical findings
 • Anterior Cord Syndrome -> Anterior spinal artery
Pathogenesis and clinical ... #diagnosis #pathophysiology ... #signs #symptoms ... #msk #orthopedics ... #neurology
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Associated with: ... - Myotonic dystrophy ... immunologic assay - MuSK ... aspiration and acute ... diagnosis #management #neurology
Pisa Syndrome (pleurothotonus) on Physical Exam
A tonic flexion of the trunk of the body to one
degrees due to dystonia ... Pathophysiology: ... Treatment: anticholinergics ... #PhysicalExam #clinical ... #neurology #posture
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
- Summary Acute ... Guillain-Barre Pathophysiology ... Guillain-Barre Clinical ... GQ1b IgG Antibody associated ... #neurology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
fluctuations PRES-Associated ... Etiology: • Pathophysiology ... Neurological symptoms ... : Acute onset 2 ... , ADEM, Acute toxic
BEE Syndromes - Non-inflammatory Causes

Immune-mediated conditions affecting the Brain, Eye, and Ear

Visual or auditory symptoms in
conjunction with symptoms ... diagnosis and treatment ... MRI lesions and clinical ... consistent with MS ... #neurology #noninflammatory
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
Pathophysiology ... : • Associated ... Clinical Manifestations ... Treatment: • ... #neurology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... ARDS to explain symptoms ... : 33% • Treatment ... At least 3 of (Acute ... diagnosis #comparison #table
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
• Or brainstem syndromes ... patients with clinically ... stimulation Clinical ... ) • Acute: ... #treatment #MS